Susquehanna International Group, LLP Vericel Corp Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$42.25 - $53.56 $299,975 - $380,276
7,100 New
7,100 $299,000
Q1 2024

May 07, 2024
BUY
$32.52 - $52.33 $1.42 Million - $2.29 Million
43,700 Added 496.59%
52,500 $2.73 Million
Q4 2023

Feb 14, 2024
BUY
$30.85 - $37.09 $15,425 - $18,545
500 Added 6.02%
8,800 $313,000
Q3 2023

Nov 14, 2023
BUY
$31.69 - $39.25 $91,901 - $113,825
2,900 Added 53.7%
8,300 $278,000
Q2 2023

Aug 11, 2023
SELL
$29.0 - $38.37 $81,200 - $107,436
-2,800 Reduced 34.15%
5,400 $202,000
Q1 2023

May 16, 2023
BUY
$23.85 - $31.34 $195,570 - $256,988
8,200 New
8,200 $240,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.8M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.48B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email